292 related articles for article (PubMed ID: 28043009)
1. Re-evaluation the immune efficacy of Newcastle disease virus vaccine in commercial laying chickens.
Han Q; Gao X; Wu P; Xiao S; Wang X; Liu P; Tong L; Hao H; Zhang S; Dang R; Yang Z
Res Vet Sci; 2017 Apr; 111():63-66. PubMed ID: 28043009
[TBL] [Abstract][Full Text] [Related]
2. Recombinant NDV expressing cytokines or fliC confers a quick immune response against NDV challenge and resistance to maternal antibody.
Zhang T; Liu Y; Wang H; Zhang X; Zhu S; Xu P; Yin J; Ren G; Liu J; Li D
Vet Microbiol; 2016 Nov; 196():107-117. PubMed ID: 27939146
[TBL] [Abstract][Full Text] [Related]
3. Advancement in vaccination against Newcastle disease: recombinant HVT NDV provides high clinical protection and reduces challenge virus shedding with the absence of vaccine reactions.
Palya V; Kiss I; Tatár-Kis T; Mató T; Felföldi B; Gardin Y
Avian Dis; 2012 Jun; 56(2):282-7. PubMed ID: 22856183
[TBL] [Abstract][Full Text] [Related]
4. Protection of chickens against overt clinical disease and determination of viral shedding following vaccination with commercially available Newcastle disease virus vaccines upon challenge with highly virulent virus from the California 2002 exotic Newcastle disease outbreak.
Kapczynski DR; King DJ
Vaccine; 2005 May; 23(26):3424-33. PubMed ID: 15837366
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the Impact of Different Administration Routes on the Efficacy of a Thermoresistant Newcastle Disease Vaccine in Chickens.
Hassanzadeh M; Abdoshah M; Yousefi AR; Masoudi S
Viral Immunol; 2020 Jun; 33(5):361-366. PubMed ID: 31976824
[TBL] [Abstract][Full Text] [Related]
6. Protection and antibody response caused by turkey herpesvirus vector Newcastle disease vaccine.
Esaki M; Godoy A; Rosenberger JK; Rosenberger SC; Gardin Y; Yasuda A; Dorsey KM
Avian Dis; 2013 Dec; 57(4):750-5. PubMed ID: 24597117
[TBL] [Abstract][Full Text] [Related]
7. Newcastle disease virus vectored infectious laryngotracheitis vaccines protect commercial broiler chickens in the presence of maternally derived antibodies.
Yu Q; Spatz S; Li Y; Yang J; Zhao W; Zhang Z; Wen G; Garcia M; Zsak L
Vaccine; 2017 Feb; 35(5):789-795. PubMed ID: 28052812
[TBL] [Abstract][Full Text] [Related]
8. Specific antibody-mediated immunity in the reproductive tract of laying chickens immunized against Newcastle disease with conventional attenuated and inactivated vaccines.
Rauw F; Nguyen TG; Ngabirano E; Marché S; Lambrecht B
Avian Pathol; 2017 Aug; 46(4):434-441. PubMed ID: 28290220
[TBL] [Abstract][Full Text] [Related]
9. Effect of phylogenetic diversity of velogenic Newcastle disease virus challenge on virus shedding post homologous and heterologous DNA vaccination in chickens.
Mohamed MH; Abdelaziz AM; Kumar S; Al-Habib MA; Megahed MM
Avian Pathol; 2016; 45(2):228-34. PubMed ID: 26813237
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of an inactivated bivalent vaccine against the prevalent strains of Newcastle disease and H9N2 avian influenza.
Zhao J; Yang H; Xu H; Ma Z; Zhang G
Virol J; 2017 Mar; 14(1):56. PubMed ID: 28302119
[TBL] [Abstract][Full Text] [Related]
11. Recombinant Newcastle disease virus (NDV) La Sota expressing the haemagglutinin-neuraminidase protein of genotype VII NDV shows improved protection efficacy against NDV challenge.
Bu YW; Yang HM; Jin JH; Zhao J; Xue J; Zhang GZ
Avian Pathol; 2019 Apr; 48(2):91-97. PubMed ID: 30465608
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of Newcastle disease LaSota vaccine-induced hemagglutination inhibition antibodies against challenges with heterologous virulent strains of genotypes VII and IX.
Liu M; Shen X; Li J; Yu Y; Fan J; Jia X; Dai Y
Vet Immunol Immunopathol; 2023 May; 259():110591. PubMed ID: 37030151
[TBL] [Abstract][Full Text] [Related]
13. Evaluation and Comparison of the Potential Immunogenicity of Two Commercial Inactivated Bivalent Newcastle and Avian Influenza Vaccines in SPF Chicken.
Mehrabanpour M
Arch Razi Inst; 2019 Sep; 74(3):251-257. PubMed ID: 31592590
[TBL] [Abstract][Full Text] [Related]
14. Characterization of live LaSota vaccine strain-induced protection in chickens upon early challenge with a virulent Newcastle disease virus of heterologous genotype.
Cornax I; Miller PJ; Afonso CL
Avian Dis; 2012 Sep; 56(3):464-70. PubMed ID: 23050461
[TBL] [Abstract][Full Text] [Related]
15. Comparison of protection and viral shedding following vaccination with Newcastle disease virus strains of different genotypes used in vaccine formulation.
Wajid A; Basharat A; Bibi T; Rehmani SF
Trop Anim Health Prod; 2018 Oct; 50(7):1645-1651. PubMed ID: 29728823
[TBL] [Abstract][Full Text] [Related]
16. Comparative efficacy of commercial inactivated Newcastle disease virus vaccines against Newcastle disease virus genotype VII in broiler chickens.
Sedeik ME; Elbestawy AR; El-Shall NA; Abd El-Hack ME; Saadeldin IM; Swelum AA
Poult Sci; 2019 May; 98(5):2000-2007. PubMed ID: 30561723
[TBL] [Abstract][Full Text] [Related]
17. Antigenic differences among Newcastle disease virus strains of different genotypes used in vaccine formulation affect viral shedding after a virulent challenge.
Miller PJ; King DJ; Afonso CL; Suarez DL
Vaccine; 2007 Oct; 25(41):7238-46. PubMed ID: 17719150
[TBL] [Abstract][Full Text] [Related]
18. Antigenic variation of LaSota and genotype VII Newcastle disease virus (NDV) and their efficacy against challenge with velogenic NDV.
Yang HM; Zhao J; Xue J; Yang YL; Zhang GZ
Vaccine; 2017 Jan; 35(1):27-32. PubMed ID: 27889255
[TBL] [Abstract][Full Text] [Related]
19. Molecular and biological characterization of the immunological potency of Newcastle disease virus oil emulsion-inactivated vaccines prepared from field isolate obtained from vaccinated chickens outbreak.
Hassan MI; Abd El-Azeem MW; Selim A; Sultan S
Braz J Microbiol; 2020 Jun; 51(2):815-826. PubMed ID: 31840214
[TBL] [Abstract][Full Text] [Related]
20. Development of a virosome vaccine for Newcastle disease virus.
Kapczynski DR; Tumpey TM
Avian Dis; 2003; 47(3):578-87. PubMed ID: 14562884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
